Market Place
Sourcing Support
Silodosin,Elagolix sodium,Daprodustat & Vonprazon Fumarate Gained WC certificate
04 Jun 2024 //
PRESS RELEASE
Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions
28 Mar 2024 //
PRESS RELEASE
GSK scraps plan to launch oral anemia drug beyond US, Japan
27 Jul 2023 //
FIERCE PHARMA
Ami Lifescices announce that USDMF for Daprodustat API has been filed US FDA.
30 Jun 2023 //
PRESS RELEASE
GSK receives positive CHMP opinion recommending authorisation of daprodustat
26 Jun 2023 //
PRESS RELEASE
U.S. FDA approves GSK`s anemia drug for patients on dialysis
02 Feb 2023 //
REUTERS
GSK reports outcome from US FDA Advisory Committee meeting on daprodustat for anaemia of CKD
27 Oct 2022 //
PRESS RELEASE
FDA raises safety questions with GSK`s potential CKD drug ahead of adcomm
26 Oct 2022 //
ENDPTS
GSK’s daprodustat will have to face FDA advisory committee
08 Sep 2022 //
PHARMAPHORUM
Could the third time be the charm for an oral anemia med at FDA?
19 Apr 2022 //
FIERCEPHARMA
EMA accepts GSK’s MAA for daprodustat for treatment of anaemia of CKD
02 Mar 2022 //
PHARMABIZ
GSK pulls off clean sweep of endpoint hits in anemia phase 3
09 Nov 2021 //
FIERCEBIOTECH
Positive results for GSK’s anaemia drug daprodustat
08 Nov 2021 //
PHARMATIMES
Japan grants approval for GSK’s Duvroq to treat CKD-related anaemia
29 Jun 2020 //
PHARMACEUTICAL-TECHNOLOGY
GlaxoSmithKline clears regulatory hurdle in Japan for `Duvroq`
29 Jun 2020 //
HL
GSK`s ViiV reports positive data for long-acting two-drug HIV therapy
23 Aug 2019 //
BIOPHARMADIVE
GSK submits its first application for daprodustat in Japan
22 Aug 2019 //
ENDPTS
GSK files for Japanese approval of oral anemia drug
21 Aug 2019 //
FIERCE BIOTECH
GSK phase 3 study to evaluate daprodustat meets primiary endpoint
30 Oct 2018 //
PHARMABIZ
Glaxo`s daprodustat on par with Amgen`s Aranesp in late-stage study in Japan
30 Oct 2018 //
SEEKING ALPHA
Akebia, Keryx to merge, creating kidney disease specialist
29 Jun 2018 //
FIERCE BIOTECH
Mitsubishi Tanabe backs Akebia PhIII with a $350M Asian deal for vadadustat
15 Dec 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.